+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biomarker Validation"

Diagnostic Exosome Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Diagnostic Exosome Biomarkers - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
From
Neurological Biomarkers - Global Strategic Business Report 2026 - Product Thumbnail Image

Neurological Biomarkers - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 389 Pages
  • Global
From
From
From
From
Biomarkers - Global Strategic Business Report 2026 - Product Thumbnail Image

Biomarkers - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 732 Pages
  • Global
From
From
From
Biomarker Development Pipeline Analysis, 2026 (Q2 Update) - Product Thumbnail Image

Biomarker Development Pipeline Analysis, 2026 (Q2 Update)

  • Report
  • August 2026
  • 182 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Biomarker validation is the process of determining the accuracy and reliability of a biomarker for use in medical research and diagnostics. It involves the evaluation of the biomarker's ability to accurately measure a biological process or disease state, as well as its ability to predict the outcome of a medical intervention. The validation process typically includes laboratory testing, clinical trials, and statistical analysis. The biomarker validation market is a rapidly growing sector of the biotechnology industry, driven by the increasing demand for personalized medicine and the need for more accurate and reliable biomarkers. Companies in this market are focused on developing and validating biomarkers for a variety of diseases and conditions, including cancer, cardiovascular disease, and neurological disorders. Some of the major companies in the biomarker validation market include Illumina, Qiagen, Thermo Fisher Scientific, Roche, and Agilent Technologies. Show Less Read more